The Predictive Value of MAP2K1/2 Mutations on Efficiency of Immunotherapy in Melanoma
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2021.785526
Abstract: Background MAP2K1/2 genes are mutated in approximately 8% of melanoma patients; however, the impact of MAP2K1/2 gene alterations on the efficiency of immunotherapy has not been clarified. This study focused on the correlation between MAP2K1/2… read more here.
Keywords: map2k1; anti ctla; map2k1 mutations; treatment ... See more keywords